BRIEF published on 02/22/2025 at 08:35, 1 year 3 months ago Sanofi-Teva: Duvakitug Promises for Inflammatory Bowel Diseases Ulcerative Colitis Crohn's Disease Duvakitug RELIEVE UCCD Sanofi-Teva
BRIEF published on 02/22/2025 at 03:10, 1 year 3 months ago Skeena Resources Files Final Prospectus for C$70.5 Million Financing Flow-through Shares Regulatory Approvals Bought Deal Offering Skeena Resources Final Prospectus
BRIEF published on 02/22/2025 at 03:10, 1 year 3 months ago Skeena Resources dépose un prospectus final pour un financement de 70,5 millions $ CA Actions Accréditives Approbations Réglementaires Ressources Skeena Prospectus Final Offre De Prise Ferme
BRIEF published on 02/22/2025 at 01:40, 1 year 3 months ago BioNxt Solutions Inc. Clarifies Promotional Activity Agreements Investor Relations German Market BioNxt Solutions Promotional Activities Option Plan
BRIEF published on 02/22/2025 at 01:40, 1 year 3 months ago BioNxt Solutions Inc. clarifie les accords d'activités promotionnelles Marché Allemand Relations Avec Les Investisseurs Solutions BioNxt Plan D'options Activités Promotionnelles
BRIEF published on 02/22/2025 at 01:05, 1 year 3 months ago AI/ML Innovations Inc. Announces AGM Results Digital Health Stock Option Plan AI/ML Innovations AGM Results Board Election
BRIEF published on 02/22/2025 at 01:05, 1 year 3 months ago AI/ML Innovations Inc. annonce les résultats de son assemblée générale annuelle Santé Numérique Plan D'options D'achat D'actions Élection Du Conseil D'administration Innovations En IA/ML Résultats De L'Assemblée Générale
BRIEF published on 02/22/2025 at 00:35, 1 year 3 months ago Supreme Critical Metals Inc. Appoints New CFO Chief Financial Officer Capital Markets Corporate Finance Supreme Critical Metals Chris Gulka
BRIEF published on 02/22/2025 at 00:35, 1 year 3 months ago Supreme Critical Metals Inc. nomme un nouveau directeur financier Directeur Financier Finance D'entreprise Marchés Des Capitaux Métaux Critiques Suprêmes Chris Gulka
BRIEF published on 02/22/2025 at 00:10, 1 year 3 months ago Onco-Innovations Subsidiary Files Provisional Patent for AI Platform SynoGraph Cancer Treatment Patent Filing Onco-Innovations AI In Medicine SynoGraph
Published on 05/23/2026 at 19:45, 9 hours 55 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 2 hours ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 2 hours ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 3 hours ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 3 hours ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/24/2026 at 05:35, 5 minutes ago CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 13 hours 10 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 13 hours 43 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 7 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 1 day 7 hours ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:35, 1 day 10 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 11 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 11 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 16 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 16 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
